ir.ziopharm.comInvestors Home | ZIOPHARM Oncology, Inc.
ir.ziopharm.com Profile
Ir.ziopharm.com is a subdomain of Ziopharm.com, which was created on 2004-01-12,making it 20 years ago.
Description：The Investor Relations website contains information about ZIOPHARM Oncology, Inc.'s business for stockholders, potential investors, and financial...
Keywords：Oncology, ziopharm, cancer, research, DNA Thearapeutics, medical,...
Discover ir.ziopharm.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.ziopharm.com Information
| HomePage size: 58.02 KB |
| Page Load Time: 0.614786 Seconds |
| Website IP Address: 173.223.52.137 |
ir.ziopharm.com Similar Website
| Maryland Real Estate Investors Association - Maryland Real Estate Investors Association |
| Western Midstream - Investors - Investors |
| Radiation Oncology: Radiotherapy, SBRT, Brachytherapy | UCLA Radiation Oncology, Los Angeles, CA. |
| OMNOVA Solutions - Investors - Investors |
| Oncology Nursing Society (ONS), Oncology Nursing Society Career Center|Find Your Career Here |
| Investors | Marathon Oil Corporation - Investors |
| Welcome to the NRG Oncology Biospecimen Bank - San Francisco Website | NRG Oncology Biospecimen Bank |
| Axalta Coating Systems - Investors - Investors Overview |
| Nashville Oncology Associates / SCRI Oncology Partners
- Navigating Care |
| Radiation Oncology | Radiation Oncology | Stanford Medicine |
| Connected Investors | Connect With Real Estate Investors |
| American Society for Radiation Oncology (ASTRO), ASTRO Radiation Oncology Career Center|Find Your Ca |
| Investors - Toromont Industries Ltd. - Investors |
| ESGO Gynae-Oncology Guidelines | ESGO Gynaecological Oncology Guidelines |
ir.ziopharm.com PopUrls
| Investors | Alaunos https://ir.ziopharm.com/ |
ir.ziopharm.com Httpheader
| Accept-Ranges: bytes |
| Content-Encoding: gzip |
| Content-Language: en |
| Content-Type: text/html; charset=UTF-8 |
| device: desktop |
| ETag: "1583600061" |
| Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
| Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
| Last-Modified: Sat, 07 Mar 2020 16:54:21 GMT |
| Link: http://ir.ziopharm.com/; rel="shortlink", http://ir.ziopharm.com/; rel="canonical", https://ir.ziopharm.com/investor-relations; rel="alternate"; hreflang="en", https://ir.ziopharm.com/investor-relations; rel="revision" |
| Referrer-Policy: no-referrer-when-downgrade |
| Server: nginx |
| X-Age: 0 |
| X-Content-Type-Options: nosniff |
| X-Drupal-Dynamic-Cache: UNCACHEABLE |
| X-Frame-Options: SAMEORIGIN |
| X-Generator: Drupal 8 (https://www.drupal.org) |
| X-Request-ID: v-4ab3fe9a-6094-11ea-819a-9f3a78cc1b8f |
| X-UA-Compatible: IE=edge |
| X-XSS-Protection: 1; mode=block |
| Content-Length: 12146 |
| X-EdgeConnect-MidMile-RTT: 42, 42 |
| X-EdgeConnect-Origin-MEX-Latency: 508, 508 |
| Cache-Control: public, max-age=0, s-maxage=1800 |
| Expires: Sat, 07 Mar 2020 16:54:21 GMT |
| Date: Sat, 07 Mar 2020 16:54:21 GMT |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| Set-Cookie: SimpleSAMLSessionID=f09d28802f3b4966c87cc5d88a42b280; path=/; secure; HttpOnly, DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
| Strict-Transport-Security: max-age=15768000 ; preload |
ir.ziopharm.com Meta Info
| charset="utf-8"/ |
| content="Investors Home | ZIOPHARM Oncology, Inc." name="title"/ |
| content="ZIOPHARM Oncology, Inc." property="og:site_name"/ |
| content="website" property="og:type"/ |
| content="The Investor Relations website contains information about ZIOPHARM Oncology, Inc.'s business for stockholders, potential investors, and financial analysts." name="description"/ |
| content="https://ir.ziopharm.com/investor-relations" property="og:url"/ |
| content="Investors Home | ZIOPHARM Oncology, Inc." property="og:title"/ |
| content="Oncology, ziopharm, cancer, research, DNA Thearapeutics, medical, medicine" name="keywords"/ |
| content="no-referrer" name="referrer"/ |
| content="The Investor Relations website contains information about ZIOPHARM Oncology, Inc.'s business for stockholders, potential investors, and financial analysts." property="og:description"/ |
| content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
ir.ziopharm.com Ip Information
| Ip Country: United States |
| Latitude: 37.751 |
| Longitude: -97.822 |
ir.ziopharm.com Html To Plain Text
Controlled IL-12 T-Cell Therapy Overview CAR-T Therapies TCRs for Solid Tumors Pipeline Patients & Caregivers About Overview Management Team Board of Directors Partnerships News & Publications Press Releases Scientific and Medical Publications Videos Investors Investor Relations Investors Home Press Releases Stock Performance SEC Filings Events & Presentations Corporate Governance Investor FAQs Email Alerts list Menu Close Close Controlled IL-12 T-Cell Therapy Overview CAR-T Therapies TCRs for Solid Tumors Pipeline Patients & Caregivers About Overview Management Team Board of Directors Partnerships News & Publications Press Releases Scientific and Medical Publications Videos Investors Investors Home Press Releases Stock Performance Stock Information Historic Stock Lookup Investment Calculator Financial Reports SEC Filings Events & Presentations Corporate Governance Medical Advisory Board Board of Directors Committees & Charters Investor FAQ Email Alerts Investors & Media Multiple opportunities for immuno-oncology Investors Home Ziopharm Oncology is focused on advancing the next generation of immunotherapies to weaponize the existing immune system with Controlled IL-12 or introduce new immune system elements with Sleeping Beauty -modified T cells to this fight against cancer. In addition to developing the next generation of immuno-oncology medicines that target multiple types of cancers, we also are targeting the cost and complexity of delivering gene and cell therapies. Intra 3 mo. 6 mo. 1 yr. Press Releases Mar 02, 2020 Summary Toggle Ziopharm Oncology Reports Financial Results for Fourth Quarter and Full Year 2019 Feb 28, 2020 Summary Toggle Ziopharm Oncology Presentation at the Barclays Global Healthcare Conference to be Webcast Feb 24, 2020 Summary Toggle Ziopharm Oncology to Host Conference Call to Discuss Fourth Quarter and Full Year 2019 Results on March 2, 2020 View all press releases » Events & Presentations Mar 11, 2020 2:35 PM EDT Barclays Global Healthcare Conference Add to Outlook Add to Google Calendar Mar 2, 2020 4:30 PM EST Ziopharm Fourth Quarter 2019 Earnings Call Listen to Webcast Supporting Materials View Presentation 534.4 KB Jan 16, 2020 1:00 PM EST Ziopharm Oncology 38th Annual J.P. Morgan Healthcare Conference - Q&A Listen to Webcast View all events & presentations » Corporate Contact: Christopher Taylor, Vice President, Investor Relations and Corporate Communications (617) 502-1881 ctaylor@ziopharm.com Email Alerts Subscription RSS News Feeds Print ShareFacebook Google LinkedIn Twitter RSS © 2020 Ziopharm Oncology, Inc. Privacy Policy Terms and Conditions Contact Vimeo...
ir.ziopharm.com Whois
Domain Name: ZIOPHARM.COM Registry Domain ID: 109781540_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2024-01-08T14:52:18Z Creation Date: 2004-01-12T21:25:25Z Registry Expiry Date: 2025-01-12T21:25:25Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS47.DOMAINCONTROL.COM Name Server: NS48.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T19:47:31Z <<<